Journal
/
/
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
JoVE Journal
Cancer Research
This content is Free Access.
JoVE Journal Cancer Research
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
DOI:

06:25 min

June 14, 2021

, , , , , , ,

Chapters

  • 00:04Introduction
  • 00:59Patient-Derived Tumor Organoid Culture
  • 02:25High Throughput Assay System for Growth Inhibition
  • 03:32High Throughput Assay System with Cell Picking and Imaging for Growth Inhibition
  • 04:30Results: Estimation of Anticancer Effects on the Patient-Derived Tumor Organoids
  • 05:55Conclusion

Summary

Automatic Translation

A highly accurate in vitro high-throughput assay system was developed to evaluate anticancer drugs using patient-derived tumor organoids (PDOs), similar to cancer tissues but are unsuitable for in vitro high-throughput assay systems with 96-well and 384-well plates.

Related Videos

Read Article